Skip to main content
DIACEUTICS PLC logo

DIACEUTICS PLC — Investor Relations & Filings

Ticker · DXRX ISIN · GB00BJQTGV64 LEI · 213800VEWQBB39ZB8J81 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 277 across all filing types
Latest filing 2024-12-19 Major Shareholding Noti…
Country GB United Kingdom
Listing IL DXRX

About DIACEUTICS PLC

https://www.diaceutics.com/

Diaceutics PLC is a data analytics and end-to-end services provider focused on the development and commercialization of precision medicine diagnostics. The company supports pharmaceutical and biotech clients by providing solutions to improve the diagnostic testing ecosystem, aiming to ensure patients receive the correct personalized treatment. Its primary offering is DXRX, The Diagnostic Network®, a diagnostic commercialization platform for precision medicine. DXRX facilitates collaboration among stakeholders, including laboratories and pharmaceutical companies, in a secure marketplace and provides access to real-world diagnostic testing data. This integrated platform is designed to streamline the launch and adoption of new precision medicines.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 7435Q' and contains structured tables detailing changes in share ownership. Specifically, Section 2 is marked 'An acquisition or disposal of voting rights' with an 'X', and Section 7 and 8 detail the 'Total positions of person(s) subject to the notification obligation' and the resulting shareholding percentages (3.12%). This format is characteristic of a Major Shareholding Notification, which reports when an investor crosses a specific threshold of ownership. This aligns perfectly with the definition for Major Shareholding Notification (MRQ).
2024-12-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 4225Q' and contains the standard header/footer information associated with RNS (Regulatory News Service) releases from the London Stock Exchange. The content details a 'TR-1: Standard form for notification of major holdings' by Danske Bank A/S regarding an acquisition/disposal of voting rights, crossing a threshold. This type of mandatory disclosure regarding changes in significant share ownership directly corresponds to the Major Shareholding Notification category.
2024-12-17 English
Diaceutics Wins New $5.1m Contract
Regulatory Filings Classification · 100% confidence The document is very short (4748 characters) and announces a significant business event: 'Diaceutics Wins New $5.1m Contract'. It is disseminated via 'RNS Number' and mentions compliance with MAR regulations, indicating it is a formal regulatory announcement made through the London Stock Exchange's news service. According to Rule 2, short announcements that convey material information but are not the full report itself often fall under RPA or RNS. Since this is a general, material announcement that doesn't fit specific categories like DIV, DIRS, or ER (which usually contain financial tables), the most appropriate classification is the general regulatory filing category, RNS.
2024-12-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with "RNS Number : 5611P" and contains the standard header/footer information associated with RNS (Regulatory News Service) releases from the London Stock Exchange. The content itself is a "TR-1: Standard form for notification of major holdings," which details changes in significant share ownership (crossing a threshold to 14.01%). This type of mandatory disclosure regarding shareholdings falls under regulatory reporting. Since there is a specific category for 'Major Shareholding Notification' (MRQ), that is the most precise fit. While RNS is a general category, MRQ is more specific to the content type.
2024-12-10 English
Awarded UK Research Institute Grant Funding of £1m
Regulatory Filings Classification · 99% confidence The document starts with 'RNS Number : 6548O' and concludes with information about RNS, the news service of the London Stock Exchange, stating it is approved by the FCA as a Primary Information Provider. The content announces a specific, non-financial event: Diaceutics being awarded £1m in grant funding. This is a material, time-sensitive announcement made via the regulatory news service. Since it is a general regulatory announcement that doesn't fit into specific categories like ER, CAP, or DIV, the most appropriate classification is the general regulatory filing category.
2024-12-05 English
Total Voting Rights
Director's Dealing Classification · 99% confidence The document is an RNS announcement dated December 3, 2024, detailing share transactions by Persons Discharging Managerial Responsibilities (PDMRs) under employee share incentive plans (SIP Schemes). It explicitly mentions 'PDMR Shareholding/Share Incentive Plan' and includes detailed tables conforming to 'Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014'. This type of filing, which reports insider transactions (director's dealing), is specifically covered by the 'Director's Dealing (Code: DIRS)' definition. Although it is distributed via RNS, the specific content points directly to DIRS rather than the general RNS fallback.
2024-12-03 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.